RA
GILD icon

RFG Advisory’s Gilead Sciences GILD Stock Holding History

RFG Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Buy
12,955
+119
+0.9% +$15.7K 0.03% 423
2026
Q1 		$1.79M Sell
12,836
-369
-3% -$51.7K 0.03% 361
2025
Q4 		$1.62M Buy
13,205
+283
+2% +$34.4K 0.03% 393
2025
Q3 		$1.43M Buy
12,922
+162
+1% +$18.4K 0.03% 397
2025
Q2 		$1.41M Sell
12,760
-614
-5% -$65.3K 0.03% 367
2025
Q1 		$1.5M Sell
13,374
-536
-4% -$55.3K 0.04% 325
2024
Q4 		$1.28M Buy
13,910
+581
+4% +$52.3K 0.04% 326
2024
Q3 		$1.12M Buy
13,329
+1,509
+13% +$115K 0.03% 345
2024
Q2 		$811K Sell
11,820
-10,694
-47% -$714K 0.03% 385
2024
Q1 		$1.65M Buy
22,514
+3,249
+17% +$250K 0.06% 259
2023
Q4 		$1.56M Buy
19,265
+2,219
+13% +$173K 0.06% 244
2023
Q3 		$1.28M Sell
17,046
-3,732
-18% -$287K 0.06% 243
2023
Q2 		$1.6M Buy
20,778
+1,541
+8% +$123K 0.07% 196
2023
Q1 		$1.6M Buy
19,237
+275
+1% +$22.8K 0.08% 189
2022
Q4 		$1.6M Sell
18,962
-274
-1% -$21.7K 0.08% 186
2022
Q3 		$1.58M Buy
19,236
+945
+5% +$59.6K 0.09% 176
2022
Q2 		$1.12M Buy
18,291
+8,403
+85% +$520K 0.06% 217
2022
Q1 		$588K Sell
9,888
-36
-0.4% -$2.3K 0.04% 284
2021
Q4 		$721K Buy
9,924
+1,172
+13% +$80.7K 0.05% 243
2021
Q3 		$611K Buy
8,752
+116
+1% +$8.15K 0.05% 244
2021
Q2 		$595K Sell
8,636
-31
-0.4% -$2.07K 0.05% 240
2021
Q1 		$560K Sell
8,667
-1,879
-18% -$121K 0.06% 233
2020
Q4 		$665K Buy
10,546
+2,978
+39% +$180K 0.09% 194
2020
Q3 		$478K Buy
7,568
+589
+8% +$40.8K 0.07% 238
2020
Q2 		$537K Buy
6,979
+3,409
+95% +$261K 0.08% 198
2020
Q1 		$267K Buy
3,570
+363
+11% +$25.1K 0.05% 277
2019
Q4 		$208K Buy
+3,207
New +$209K 0.04% 341
2019
Q3 		– Sell
-3,408
Closed -$231K – 344
2019
Q2 		$231K Buy
+3,408
New +$224K 0.05% 274
2019
Q1 		– Sell
-6,443
Closed -$403K – 285
2018
Q4 		$403K Sell
6,443
-1,148
-15% -$80.2K 0.1% 160
2018
Q3 		$586K Buy
7,591
+2,236
+42% +$169K 0.15% 134
2018
Q2 		$379K Sell
5,355
-372
-6% -$26.3K 0.11% 142
2018
Q1 		$432K Sell
5,727
-467
-8% -$37.1K 0.16% 103
2017
Q4 		$460K Buy
6,194
+198
+3% +$15K 0.21% 105
2017
Q3 		$491K Buy
5,996
+273
+5% +$20.9K 0.3% 68
2017
Q2 		$397K Buy
5,723
+56
+1% +$3.73K 0.27% 71
2017
Q1 		$377K Sell
5,667
-592
-9% -$41.6K 0.28% 81
2016
Q4 		$483K Hold
6,259
– – 0.46% 40
2016
Q3 		$484K Buy
6,259
+255
+4% +$20.7K 0.44% 41
2016
Q2 		$501K Sell
6,004
-10
-0.2% -$887 0.44% 42
2016
Q1 		$552K Buy
6,014
+2,643
+78% +$238K 0.43% 35
2015
Q4 		$341K Sell
3,371
-4,845
-59% -$504K 0.25% 35
2015
Q3 		$807K Sell
8,216
-1,394
-15% -$155K 2.6% 4
2015
Q2 		$1.13M Buy
9,610
+6,570
+216% +$718K 0.51% 37
2015
Q1 		$309K Buy
+3,040
New +$309K 0.24% 30

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

RFG Advisory's GILD Position: Q2 2026 in Review

RFG Advisory increased its Gilead Sciences (GILD) stake by 0.93% in Q2 2026, buying an estimated $15.7K and bringing the position to 12,955 shares worth $1.64M. The position accounts for 0.03% of the portfolio, ranked #423.

RFG Advisory first reported a position in GILD in Q1 2015 and has held it in 44 quarters since. The position peaked at $1.79M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • RFG Advisory held 12,955 shares of Gilead Sciences worth $1.64M as of Q2 2026.
  • RFG Advisory bought 119 Gilead Sciences shares in Q2 2026, an estimated $15.7K.
  • Gilead Sciences made up 0.03% of RFG Advisory's portfolio in Q2 2026, its #423 holding.
  • RFG Advisory first reported a position in Gilead Sciences in Q1 2015 and has held it in 44 quarters since.
  • RFG Advisory's Gilead Sciences position peaked at $1.79M in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.